NCT02502721View on ClinicalTrials.gov

A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

August 31, 2015

Conditions
Healthy
Interventions
DRUG

DWC20151

DRUG

DWC20152

Trial Locations (1)

Unknown

Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY